Cutler Group LLC / CA - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$492
+10.1%
29,700
-20.6%
0.07%
+47.8%
Q1 2023$447
+81.0%
37,400
+274.0%
0.05%
+130.0%
Q4 2022$247
-99.8%
10,000
-17.0%
0.02%
+122.2%
Q3 2022$129,000
-16.2%
12,054
+63.2%
0.01%
-10.0%
Q2 2022$154,000
-65.1%
7,386
-90.1%
0.01%
-56.5%
Q1 2022$441,000
+70.9%
74,402
+66.0%
0.02%
+130.0%
Q4 2021$258,000
+87.0%
44,832
+296.7%
0.01%
+66.7%
Q3 2021$138,000
+165.4%
11,300
+583.2%
0.01%
+200.0%
Q2 2021$52,000
-46.9%
1,654
-37.8%
0.00%
-60.0%
Q1 2021$98,000
+1533.3%
2,660
+195.6%
0.01%
Q4 2020$6,000
-98.3%
900
-87.7%
0.00%
-100.0%
Q3 2020$361,000
+1404.2%
7,300
+4462.5%
0.02%
+1000.0%
Q2 2020$24,000
-88.5%
160
-98.5%
0.00%
-81.8%
Q1 2020$208,000
-73.4%
11,000
-15.8%
0.01%
-77.1%
Q4 2019$783,000
+252.7%
13,061
-5.4%
0.05%
+140.0%
Q3 2019$222,000
-53.2%
13,800
+72.0%
0.02%
-54.5%
Q2 2019$474,000
+8.5%
8,025
-38.9%
0.04%
-2.2%
Q1 2019$437,000
+893.2%
13,125
+1540.6%
0.04%
+1025.0%
Q4 2018$44,000
-47.6%
800
-94.2%
0.00%
-20.0%
Q3 2018$84,000
+394.1%
13,800
+1433.3%
0.01%
+400.0%
Q2 2018$17,000
+70.0%
900
+80.0%
0.00%0.0%
Q1 2018$10,000
-9.1%
500
+25.0%
0.00%
Q4 2017$11,0004000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders